Wall Street brokerages expect that Nextgen Healthcare Inc (NASDAQ:NXGN) will report earnings per share of $0.15 for the current fiscal quarter, Zacks reports. Ten analysts have issued estimates for Nextgen Healthcare’s earnings, with estimates ranging from $0.10 to $0.21. Nextgen Healthcare reported earnings per share of $0.16 in the same quarter last year, which would suggest a negative year over year growth rate of 6.3%. The company is expected to report its next earnings report on Thursday, May 23rd.

On average, analysts expect that Nextgen Healthcare will report full-year earnings of $0.77 per share for the current financial year, with EPS estimates ranging from $0.74 to $0.84. For the next year, analysts anticipate that the company will post earnings of $0.86 per share, with EPS estimates ranging from $0.77 to $0.90. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Nextgen Healthcare.

Nextgen Healthcare (NASDAQ:NXGN) last issued its quarterly earnings data on Wednesday, January 23rd. The company reported $0.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.01. The firm had revenue of $130.87 million during the quarter, compared to analysts’ expectations of $130.79 million. Nextgen Healthcare had a net margin of 1.80% and a return on equity of 10.66%.

A number of brokerages have weighed in on NXGN. Zacks Investment Research raised shares of Nextgen Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $23.00 price target on shares of Nextgen Healthcare in a research note on Thursday, December 6th. TheStreet lowered shares of Nextgen Healthcare from a “b-” rating to a “c+” rating in a research note on Wednesday, November 21st. Finally, Dougherty & Co raised shares of Nextgen Healthcare from a “neutral” rating to a “buy” rating and set a $19.00 price target on the stock in a research note on Friday, January 11th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $18.50.

Several hedge funds have recently made changes to their positions in NXGN. Bank of Montreal Can bought a new stake in shares of Nextgen Healthcare in the third quarter worth $165,000. Arizona State Retirement System bought a new stake in Nextgen Healthcare during the third quarter worth $1,384,000. State Board of Administration of Florida Retirement System bought a new stake in Nextgen Healthcare during the third quarter worth $700,000. Comerica Bank bought a new stake in Nextgen Healthcare during the third quarter worth $912,000. Finally, Wells Fargo & Company MN bought a new stake in Nextgen Healthcare during the third quarter worth $1,745,000. 69.02% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ NXGN opened at $17.06 on Thursday. The company has a market cap of $1.11 billion, a P/E ratio of 29.93, a PEG ratio of 3.36 and a beta of 1.16. The company has a quick ratio of 1.31, a current ratio of 1.32 and a debt-to-equity ratio of 0.07. Nextgen Healthcare has a 52-week low of $13.01 and a 52-week high of $23.73.

Nextgen Healthcare Company Profile

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Read More: Technical Analysis

Get a free copy of the Zacks research report on Nextgen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.